Stratification based on prelymphodepletion C-reactive protein, ferritin can classify patients into high, intermediate, and low risk.
News
Changes to modern treatment protocols for pediatric Hodgkin lymphoma seem to have reduced late cardiotoxicity.
Researchers sought to better characterize the disease features, patient characteristics, and the effects of immunodeficiency on survival among patients with plasmablastic lymphoma.
Researchers sought to determine whether MRD status would be predictive of outcomes after induction and during maintenance in previously untreated patients with FL.
Researchers sought to determine whether golidocitinib would have antitumor activity among patients with relapsed/refractory PTCL.
Meta-analysis identifies risk factors for venous thromboembolism in patients with lymphoma.
CD5-directed CAR-T cells can produce responses in patients with relapsed or refractory T-cell lymphoma, data suggest.
Liso-cel is cost-effective as second-line therapy for diffuse large B-cell lymphoma, according to researchers.
Researchers sought to determine whether frontline tazemetostat with R-CHOP maintenance would induce metabolic response in patients with high-risk FL.
Researchers sought to determine the cost-effectiveness of axi-cel and liso-cel compared with chemoimmunotherapy and ASCT as second-line treatment for DLBCL.